I-S-23 SARMs Izongezo zokwakha umzimba kuHlumo lweZihlunu S-23 Powder CAS 1010396-29-8
Iinkcukacha eziKhawulezayo
Igama lemveliso | S-23 |
Alias | S23 |
CASE | 1010396-29-8 |
MF | I-C18H13ClF4N2O3 |
MW | 416.7540328 |
Ubunyulu | 99.50% |
Umthamo | 10mg ukuba 15mg |
IBanga | IBanga lezamayeza |
Imbonakalo | umgubo omhlophe wekristale |
Brand Nmae | Tingyi |
Umgangatho | USP |
Isitokhwe | Isitokhwe seMisa |
Iindlela zokuPakisha | yenzelwe iindlela zokupakisha ezifihliweyo, i-100% yokupasa isiqinisekiso sesiko |
Ixesha lokuzisa | kwiiyure ezili-18 emva kokuba intlawulo iqinisekisiwe |
Intlawulo | Western Union, MoneyGram, Bank Transfer, Bitcoin, Litecoin |
Ukusetyenziswa | Ukukhulelwa kwe-hormonal yamadoda, ukwandisa ubunzima bemisipha, ukunciphisa amanqatha |
S-23 umthamo
Imilinganiselo ye-S-23 inokwahluka, kwaye iya kuxhomekeka kakhulu kwinjongo.Ngokomzekelo, ukuba umsebenzisi wayefuna ukwakhiwa kwemisipha kunye nokulahlekelwa kwamafutha, umthamo we-15-25 mgs ngosuku uya kufaneleka.Kwelinye icala, ukuba umntu ebejonge ukuyisebenzisa kwiziphumo zocwangciso, idosi ephezulu ejikeleze i-50 mgs ngosuku iya kusebenza ngakumbi.Nangona kunjalo, oku akukhuthazwayo ngenxa yokuba akuzange kubekho zifundo ezenziwa ebantwini ukuphindaphinda umphumo wokukhulelwa oboniswe kwiimpuku.
Ngaphandle kwento yokuba emva kweentsuku ze-100 iigundane ziye zaphinda zafumana amanqanaba endalo e-testosterone, abantu kuya kufuneka baqhube i-PCT epheleleyo (iPost Cycle Therapy).Ekubeni i-S-23 ibangela uxinzelelo olunzima, ndingahlala ndincoma i-PCT egqibeleleyo.
S-23 Umsebenzi
I-S-23 ayigcini nje ukwandisa ubunzima be-muscle, kodwa yanciphisa ubunzima be-fat, njengoko ifundwe.IiSARM zinentwana yomfanekiso 'othambileyo' kwihlabathi ledoping.Azikukhuthazi ukukhula kwemisipha ngendlela eyenziwa ngayo i-anabolic steroids, kodwa abasebenzisi abaninzi bathi bakhuselekile.
Akukho zifundo okwangoku ezingqina oku kurhanelwa.Kodwa loo S23 ayisiyiyo enye yee-SARM ezikhuselekileyo- singathanda ukubheja ibhotile ye-BCAAs kuloo nto.I-S23 imisa ukuveliswa kwedlozi kumasende.Ngapha koko ikwenza kakuhle oku kangangokuba abaphandi bakrokrela ukuba i-S23 inokuba ngumgqatswa olungileyo wocwangciso-nzala lwamadoda.Ukuba oku kunjalo kuya kufuneka ukuba ibe yinxalenye ye-cocktail equlethe i-analogue ye-estradiol, abaphandi bafumanisa.Izilwanyana zaselabhu zaphulukana ne-libido yazo xa zanikwa i-S23 yodwa, kwaye zaphinda zafumana oku xa zanikwa i-estradiol benzoate kunye ne-S23.
Iimveliso zeSARMS ezinxulumeneyo
Igama | HAYI. | Ukusetyenziswa |
RAD140 | 1182367-47-0 | Isizukulwana esitsha sokufumana ubunzima kunye nemiphetho yokusika |
IAndarine (S4) | 401900-40-0 | i-agonist inxalenye, ejoliswe ikakhulu kunyango lwe-benign prostatic hypertrophy |
MK-677 | 15972-10-0 | I-hormone yokukhula secretagogue, unyango lokutyeba, unyango oluthembisayo kunyango lobuthathaka kubantu abadala |
I-LGD-4033 | 1165910-22-4 | Iprofayili ye-pharmacological efana naleyo ye-enobosarm, i-Ostarine, i-MK-2866 |
GW1516 | 317318-70-0 | Ukutyeba ngokugqithiseleyo, isifo seswekile, i-dyslipidemia kunye nesifo senhliziyo |
MK2866 | 841205-47-8 | Umyalelo wonyango wokuthintela i-cachexia, i-atrophy, kunye ne-sarcopenia kunye neHormone okanye i-Testoserone Replacement Therapy. |
SR9009 | 1379686-30-2 | phantsi kophuhliso kwi-Scripps Research Institute (TSRI), kwandisa inqanaba lomsebenzi we-metabolic kwizihlunu zamathambo eempuku |
Apha | 2627-69-2 | isebenza ngokungena kumachibi e-nucleoside, ukwandisa kakhulu amanqanaba e-adenosine ngexesha lokuphuka kwe-ATP |
YK11 | 431579-34-9 | I-YK11: i-SARM kunye ne-myostatin inhibitor kwenye |
S-23 COA
Into yovavanyo | Inkcazo | Isiphumo |
Imbonakalo | Umgubo omhlophe ukuya kumhlophe | Iyahambelana |
HNMR | Ihambelana nesakhiwo | Iyahambelana |
I-LCMS | Iyahambelana neMW | Iyahambelana |
Indawo yokunyibilika | 119-121℃ | Iyahambelana |
Isivavanyi | NLT 99.0% | 99.32% |
Isiphelo: Le mveliso ihambelana nomgangatho woShishino. |